Safety, Viremia and Immunogenicity of Sanofi Pasteur Tetravalent Dengue Vaccine in Adults Previously Exposed to Live, Attenuated Flaviviruses

被引：0
|
作者：
Qiao, M. [1 ]
Shaw, D. [1 ]
Forrat, R. [2 ]
Wartel-Tram, A. [2 ]
Lang, J. [3 ]
机构：
[1] Inst Drug Technol, CMAX, Adelaide, SA, Australia
[2] Sanofi Pasteur, Lyon, France
[3] Sanofi Pasteur, Ho Chi Minh City, Vietnam
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/j.ijid.2008.05.360
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E144 / E145
页数：2
相关论文
共 50 条
  • [1] Immunogenicity of sanofi pasteur tetravalent dengue vaccine
    Guy, Bruno
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S16 - S19
  • [2] Safety, viremia and immunogenicity of a tetravalent live attenuated ChimeriVax™ dengue vaccine in healthy us adults
    Kanesa-Thasan, Niranjan
    Morrison, Dennis
    Forrat, Remi
    Deary, Alison
    McCarthy, Karen
    Nichols, Rick
    Yoksan, Sutee
    Guirakhoo, Farshad
    Lang, Jean
    Bedford, Philip
    Monath, Thomas
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 181 - 182
  • [3] Toxicity, biodistribution and shedding of Sanofi Pasteur live, attenuated, tetravalent, dengue vaccine in cynomolgus monkeys
    Ravel, G.
    Mantel, N.
    Lang, J.
    Gould, S.
    TOXICOLOGY LETTERS, 2011, 205 : S244 - S244
  • [4] DEVELOPMENT OF SANOFI PASTEUR'S RECOMBINANT LIVE-ATTENUATED TETRAVALENT DENGUE VACCINE: 2009 UPDATE
    Dumas, Rafaela
    Saville, Melanie
    Guy, Bruno
    Lang, Jean
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (05): : 125 - 125
  • [5] DEVELOPMENT OF SANOFI PASTEUR TETRAVALENT DENGUE VACCINE
    Lang, Jean
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2012, 54 : S15 - S17
  • [6] Development of Sanofi Pasteur tetravalent dengue vaccine
    Guy, Bruno
    Saville, Melanie
    Lang, Jean
    HUMAN VACCINES, 2010, 6 (09): : 696 - 705
  • [7] Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial
    Durbin, Anna P.
    Pierce, Kristen K.
    Kirkpatrick, Beth D.
    Grier, Palmtama
    Sabundayo, Beulah P.
    He, Helen
    Sausser, Michele
    Russell, Amy Falk
    Martin, Jason
    Hyatt, Donna
    Cook, Melissa
    Sachs, Jeffrey R.
    Lee, Andrew Wen-Tseng
    Wang, Liman
    Coller, Beth-Ann
    Whitehead, Stephen S.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2020, 103 (02): : 855 - 863
  • [8] Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults
    Kitchener, S
    Nissen, M
    Nasveld, P
    Forrat, R
    Yoksan, S
    Lang, J
    Saluzzo, JF
    VACCINE, 2006, 24 (09) : 1238 - 1241
  • [9] EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF TETRAVAX-DV, A LIVE ATTENUATED TETRAVALENT DENGUE VACCINE
    Durbin, Anna P.
    Kirkpatrick, Beth
    Pierce, Kristen
    Elwood, Daniel
    Tibery, Cecilia
    Lewis, Robbyn
    Wanionek, Kimberli
    Thumar, Bhavin
    Luke, Catherine
    Murphy, Brian
    Subbarao, Kanta
    Whitehead, Stephen
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 248 - 248
  • [10] Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children
    Simasathien, Sriluck
    Thomas, Stephen J.
    Watanaveeradej, Veerachai
    Nisalak, Ananda
    Barberousse, Celia
    Innis, Bruce L.
    Sun, Wellington
    Putnak, J. Robert
    Eckels, Kenneth H.
    Hutagalung, Yanee
    Gibbons, Robert V.
    Zhang, Chunlin
    De La Barrera, Rafael
    Jarman, Richard G.
    Chawachalasai, Wipa
    Mammen, Mammen P., Jr.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 78 (03): : 426 - 433
12345